- Home
- AUPH vs GCT Comparison
AUPH vs GCT Comparison
Compare AUPH & GCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- GCT
- Stock Information
- Founded
- AUPH 1993
- GCT 2019
- Country
- AUPH Canada
- GCT United States
- Employees
- AUPH N/A
- GCT N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- GCT Catalog/Specialty Distribution
- Sector
- AUPH Health Care
- GCT Consumer Discretionary
- Exchange
- AUPH Nasdaq
- GCT Nasdaq
- Market Cap
- AUPH 1.1B
- GCT 685.2M
- IPO Year
- AUPH 1999
- GCT 2022
- Fundamental
- Price
- AUPH $8.86
- GCT $20.73
- Analyst Decision
- AUPH Strong Buy
- GCT Buy
- Analyst Count
- AUPH 2
- GCT 2
- Target Price
- AUPH $11.50
- GCT $20.50
- AVG Volume (30 Days)
- AUPH 1.9M
- GCT 690.0K
- Earning Date
- AUPH 07-31-2025
- GCT 08-05-2025
- Dividend Yield
- AUPH N/A
- GCT N/A
- EPS Growth
- AUPH N/A
- GCT 19.58
- EPS
- AUPH 0.27
- GCT 3.07
- Revenue
- AUPH $247,295,000.00
- GCT $1,181,871,000.00
- Revenue This Year
- AUPH $12.15
- GCT $1.98
- Revenue Next Year
- AUPH $18.31
- GCT $6.50
- P/E Ratio
- AUPH $33.04
- GCT $6.76
- Revenue Growth
- AUPH 29.20
- GCT 42.89
- 52 Week Low
- AUPH $5.20
- GCT $11.17
- 52 Week High
- AUPH $10.67
- GCT $32.43
- Technical
- Relative Strength Index (RSI)
- AUPH 64.10
- GCT 61.16
- Support Level
- AUPH $7.36
- GCT $19.61
- Resistance Level
- AUPH $9.10
- GCT $21.37
- Average True Range (ATR)
- AUPH 0.44
- GCT 0.96
- MACD
- AUPH 0.10
- GCT 0.07
- Stochastic Oscillator
- AUPH 89.53
- GCT 85.68
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About GCT GigaCloud Technology Inc
GigaCloud Technology Inc provides end-to-end and B2B e-commerce solutions for large parcel merchandise. Its B2B e-commerce platform, which is referred to as the GigaCloud Marketplace, integrates everything from discovery, payments, and logistics tools into one easy-to-use platform. It offers online and offline integrated cross-border transaction and delivery services for furniture and large merchandise. Its marketplace seamlessly connects manufacturers in Asia, with resellers in the U.S., Asia, and Europe, to execute cross-border transactions with confidence, speed, and efficiency. It offers a truly comprehensive solution that transports products from the manufacturer's warehouse to end customers, all at one fixed price.